Centrum Medyczne ENEL-MED S.A.
WSE:ENE.WA
16.9 (PLN) • At close December 14, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) PLN.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 618.546 | 494.904 | 441.144 | 399.798 | 417.691 | 371.712 | 323.728 | 273.702 | 234.658 | 213.676 | 199.76 | 180.785 | 166.289 | 137.803 |
| Cost of Revenue
| 592.59 | 484.021 | 418.95 | 369.503 | 394.09 | 348.163 | 305.661 | 252.002 | 215.529 | 192.764 | 184.586 | 175.302 | 153.331 | 129.128 |
| Gross Profit
| 25.956 | 10.883 | 22.194 | 30.295 | 23.601 | 23.549 | 18.067 | 21.7 | 19.129 | 20.912 | 15.174 | 5.483 | 12.958 | 8.675 |
| Gross Profit Ratio
| 0.042 | 0.022 | 0.05 | 0.076 | 0.057 | 0.063 | 0.056 | 0.079 | 0.082 | 0.098 | 0.076 | 0.03 | 0.078 | 0.063 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 9.915 | 9.924 | 9.25 | 7.593 | 7.657 | 9.054 | 8.461 | 7.985 | 7.657 | 8.124 | 6.048 | 6.433 | 6.27 | 4.702 |
| Selling & Marketing Expenses
| 23.594 | 27.194 | 14.564 | 12.64 | 12.583 | 13.044 | 11.702 | 9.483 | 9.515 | 7.624 | 6.918 | 6.645 | 0 | 0 |
| SG&A
| 33.87 | 37.118 | 23.814 | 20.233 | 20.24 | 22.098 | 20.163 | 17.468 | 17.172 | 15.748 | 12.966 | 13.078 | 6.27 | 4.702 |
| Other Expenses
| 0.049 | -5.943 | -3.073 | -2.846 | -0.426 | 0.115 | 0.079 | 0.015 | 0.039 | 0.038 | -1.196 | -0.147 | -0.954 | -0.782 |
| Operating Expenses
| 33.821 | 31.175 | 20.741 | 17.387 | 19.814 | 21.836 | 19.435 | 17.118 | 16.84 | 15.375 | 11.77 | 12.783 | 5.316 | 3.92 |
| Operating Income
| -7.865 | -20.332 | 4.732 | 3.954 | 6.692 | 1.588 | -1.9 | 4.359 | 0.878 | 40.84 | 3.535 | -7.755 | 7.39 | 4.55 |
| Operating Income Ratio
| -0.013 | -0.041 | 0.011 | 0.01 | 0.016 | 0.004 | -0.006 | 0.016 | 0.004 | 0.191 | 0.018 | -0.043 | 0.044 | 0.033 |
| Total Other Income Expenses Net
| 17.675 | -7.61 | -4.116 | -8.433 | -7.709 | -1.557 | -1.609 | -1.192 | 0.409 | 0.699 | -2.61 | -2.216 | -1.683 | -2.848 |
| Income Before Tax
| 9.81 | -27.942 | 0.616 | -4.479 | -1.017 | 0.031 | -3.509 | 3.167 | 1.287 | 41.539 | 0.925 | -9.971 | 5.707 | 1.702 |
| Income Before Tax Ratio
| 0.016 | -0.056 | 0.001 | -0.011 | -0.002 | 0 | -0.011 | 0.012 | 0.005 | 0.194 | 0.005 | -0.055 | 0.034 | 0.012 |
| Income Tax Expense
| 1.581 | -4.384 | 1.506 | -1.083 | 1.451 | 0.767 | -0.203 | 1.448 | 0.739 | 0.082 | 0.458 | -1.14 | 1.62 | 0.733 |
| Net Income
| 8.229 | -23.558 | -0.89 | -3.396 | -2.468 | -0.735 | -3.306 | 1.833 | 0.557 | 41.544 | 0.467 | -8.831 | 4.087 | 0.969 |
| Net Income Ratio
| 0.013 | -0.048 | -0.002 | -0.008 | -0.006 | -0.002 | -0.01 | 0.007 | 0.002 | 0.194 | 0.002 | -0.049 | 0.025 | 0.007 |
| EPS
| 0.29 | -0.83 | -0.037 | -0.14 | -0.1 | -0.031 | -0.14 | 0.07 | 0.02 | 1.76 | 0.11 | -0.37 | 0.2 | 0.06 |
| EPS Diluted
| 0.29 | -0.83 | -0.037 | -0.14 | -0.1 | -0.031 | -0.14 | 0.07 | 0.02 | 1.76 | 0.11 | -0.37 | 0.2 | 0.06 |
| EBITDA
| 63.513 | 41.787 | 61.354 | 60.893 | 63.727 | 23.958 | 18.337 | 21.182 | 15.089 | 15.952 | 17.64 | 7.207 | 18.929 | 14.957 |
| EBITDA Ratio
| 0.103 | 0.084 | 0.139 | 0.152 | 0.153 | 0.064 | 0.057 | 0.077 | 0.064 | 0.075 | 0.088 | 0.04 | 0.114 | 0.109 |